Skin manifestations associated with Glucagon-Like Peptide-1 (GLP-1) receptor agonist use for weight loss: A cross-sectional analysis. (2026). Journal of Pakistan Association of Dermatologists, 36(1), 3-9. https://doi.org/10.66344/jpad.v36i1.3221